Jinming Yu, MD

Professor Jinming Yu, MD, PhD
 

President, Shandong Cancer Hospital and Institute
Jinan, Shandong
China

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival (PFS) and overall (OS)? Video

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival (PFS) and overall (OS)?

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival (PFS) and overall (OS)?
Professor Jinming Yu, MD, PhD

Professor Jinming Yu, MD, PhD

What evidence and guidelines have supported the move by oncologists toward molecular, NGS-generated mutational drivers as the optimal approach to precision cancer medicine? Video

What evidence and guidelines have supported the move by oncologists toward molecular, NGS-generated mutational drivers as the optimal approach to precision cancer medicine?

What evidence and guidelines have supported the move by oncologists toward molecular, NGS-generated mutational drivers as the optimal approach to precision cancer medicine?
Professor Jinming Yu, MD, PhD

Professor Jinming Yu, MD, PhD

What kind of clinical samples are required to implement next generation sequencing (NGS)? Can NGS be applied to samples other than FFPE? Video

What kind of clinical samples are required to implement next generation sequencing (NGS)? Can NGS be applied to samples other than FFPE?

What kind of clinical samples are required to implement next generation sequencing (NGS)? Can NGS be applied to samples other than FFPE?
Professor Jinming Yu, MD, PhD

Professor Jinming Yu, MD, PhD

PFS is improved with use of a TKI in patients with sensitizing EGFR mutations when compared with standard chemotherapy. Please summarize clinical results and implications for NGS testing. Video

PFS is improved with use of a TKI in patients with sensitizing EGFR mutations when compared with standard chemotherapy. Please summarize clinical results and implications for NGS testing.

PFS is improved with use of a TKI in patients with sensitizing EGFR mutations when compared with standard chemotherapy. Please summarize clinical results and implications for NGS testing.
Professor Jinming Yu, MD, PhD

Professor Jinming Yu, MD, PhD